Abbott India (BOM:500488) ROE % Adjusted to Book Value: 2.87% (As of Mar. 2026)


BOM:500488 Abbott India Ltd BOM:500488
89 GF Score
Price ₹27,124.95
GF Value ₹32,396.62
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Abbott India ROE % Adjusted to Book Value?

Abbott India BOM:500488 +1.35% 89 ROE % Adjusted to Book Value is 2.87% as of Mar. 2026. GuruFocus rates BOM:500488 with a GF Score™ of 89/100 and a GF Value™ of ₹32,396.62 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Abbott India's ROE % for the quarter that ended in Mar. 2026 was 33.09%. Abbott India's PB Ratio for the quarter that ended in Mar. 2026 was 11.54. Abbott India's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 2.87%.


Abbott India ROE % Adjusted to Book Value Related Terms


Abbott India ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Abbott India's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott India ROE % Adjusted to Book Value Chart

Abbott India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.21 2.15 2.25 2.31 2.99

Abbott India Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.25 0.00 2.67 0.00 2.87

BOM:500488 vs ZTS, UTHR: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott India's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Abbott India's ROE % Adjusted to Book Value falls into.


BOM:500488
89GF Score
Abbott India Ltd BOM:500488
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott India ROE % Adjusted to Book Value Calculation

Abbott India's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=34.46% / 11.54
=2.99%

Abbott India's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=33.09% / 11.54
=2.87%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 2.87% mean?
Abbott India (BOM:500488) has a ROE % Adjusted to Book Value of 2.87% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Abbott India and its competitors.
Is Abbott India's ROE % Adjusted to Book Value too high?
Abbott India's current ROE % Adjusted to Book Value is 2.87%. Overall, Abbott India has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott India's ROE % Adjusted to Book Value compare to ZTS and UTHR?
Abbott India's ROE % Adjusted to Book Value of 2.87% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Abbott India and its competitors. Abbott India's current ROE % Adjusted to Book Value is 2.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott India stock overvalued right now?
Based on GuruFocus' analysis, Abbott India (BOM:500488) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹32,396.62, compared to a current price of ₹27,124.95 — trading 16.3% below its estimated fair value. The current ROE % Adjusted to Book Value is 2.87%. Abbott India's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Abbott India (BOM:500488), the current ROE % Adjusted to Book Value is 2.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott India (BOM:500488) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott India stock appears to be undervalued. The current stock price of ₹27,124.95 is trading 16.3% below its estimated GF Value™ of ₹32,396.62. GuruFocus considers Abbott India to be Modestly Undervalued.

Key valuation signals for BOM:500488:

  • ROE % Adjusted to Book Value: 2.87%
  • GF Value™: ₹32,396.62 vs. price of ₹27,124.95 (16.3% below fair value)
  • GF Score™: 89/100 with 1 warning sign

No single metric tells the full story. See the BOM:500488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott India Business Description

Other Exchanges ABBOTINDIA:India
Address Plot C-68, G Block, 16th Floor, Godrej BKC, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400051
Abbott India Ltd is a drug manufacturing company that offers products in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. Its patient focus centers overwhelmingly on women's health and gastrointestine, gastroenterology, and hepatic care. Geographically, the majority of the company's revenue is generated in India.
89GF Score

Get the complete analysis for BOM:500488

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹27,124.95
Price
₹32,396.62
GF Value